Amelioration of macular degeneration and other ophthalmic diseases

Details for Australian Patent Application No. 2004293105 (hide)

Owner OTHERA HOLDING, INC.

Inventors Matier, William L.; Patil, Ghanshyam

Agent Callinan

Pub. Number AU-B-2004293105

PCT Pub. Number WO2005/051328

Priority 60/523,802 20.11.03 US

Filing date 22 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 9 September 2010

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/051328 Priority application(s): WO2005/051328

20 November 2008 Assignment before Grant

  Othera Pharmaceuticals, Inc. The application has been assigned to OTHERA HOLDING, INC.

9 September 2010 Application Accepted

  Published as AU-B-2004293105

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293106-Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems

2004293104-Patient selectable knee joint arthroplasty devices